CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Tianjin Chase Sun Pharmaceutical Company Limited Company Snapshot
Tianjin Chase Sun Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tianjin Chase Sun Pharmaceutical Company Limited with three other companies in this sector in China: Zhangzhou Pientzehuang Pharmaceutical Ltd (2017 sales of 3.71 billion Chinese Renmimbi [US$587.92 million] of which 51% was Pharmaceutical Business), Jiangsu Kanion Pharmaceutical Co., Ltd. (3.27 billion Chinese Renmimbi [US$518.38 million] ), and Zhuzhou Qianjin Pharmaceutical Co., Ltd. (3.18 billion Chinese Renmimbi [US$503.76 million] ).

Sales Analysis. During the year ended December of 2017, sales at Tianjin Chase Sun Pharmaceutical Company Limited were 3.37 billion Chinese Renmimbi (US$534.10 million). This is a decrease of 12.7% versus 2016, when the company's sales were 3.87 billion Chinese Renmimbi. Contributing to the drop in overall sales was the 27.8% decline in Finished Medicine, from 1.29 billion Chinese Renmimbi to 931.33 million Chinese Renmimbi. There were also decreases in sales in Granules (down 6.6% to 1.75 billion Chinese Renmimbi) and Medical Devices (down 18.6% to 239.43 million Chinese Renmimbi) . However, these declines were partially offset by the increase in sales of Excipients and Api (up 8.3% to 375.70 million Chinese Renmimbi) and Other Main Operation (up 28.3% to 74.72 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Tianjin Chase Sun Pharmaceutical Company Limited
  Stock Performance Chart for Tianjin Chase Sun Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 4.02
(Figures in Chinese Renmimbi)
1 Week -2.0%   13 Weeks 5.0%  
4 Weeks -7.2%   52 Weeks -23.4%  
 
Tianjin Chase Sun Pharmaceutical Company Limited Key Data:
  Ticker: 300026 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 3,373,991,169
(Year Ending Jan 2018).
Employees: 5,369
  Currency: Chinese Renmimbi Market Cap: 12,104,440,268
  Fiscal Yr Ends: December Shares Outstanding: 3,011,054,793
  Share Type: A Gu Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.